ResearcherAcademy of Military Medical SciencesNo recent work listed

Feng Gong

Provisional: name at one institution (moderate confidence)As of 13 November 2026

Known by name at one institution; no external author ID yet. Name as it appears in OpenAlex.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 0, last author 1)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 2

Papers, trials and grants by year

2017: 1 paper

Papers 1

Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling. Last author DOI 10.18632/oncotarget.16911 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Jin-Wen Song · 1 shared paper, 2017
- Paper Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling. DOI 10.18632/oncotarget.16911 ↗
Zhihang Zhou · 1 shared paper, 2017
- Paper Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling. DOI 10.18632/oncotarget.16911 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.